Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

From heart disease to neurodegeneration, Novartis makes bold deals in 2025 to expand its drug pipeline globally.

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

Discover the emerging field of AI-based peptide discovery and design – could this signal the beginning of a golden age for ...

The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...

As Labiotech attented the NLS Days this week, it was the occasion to learn more about the biotech industry in Sweden.

After being founded in 2017, 3T Biosciences debuted in 2022 with $40 million series A financing. As a company focused on immunotherapy, it is looking to change the future of treatment for solid tumors ...

One of the wealthiest countries in the world, Luxembourg is renowned for its gromperekichelcher (potato pancakes), fine wines, and medieval castles. An economic powerhouse in Europe, the country’s ...

Named after French neurologist Georges Gilles de la Tourette, who first described the disorder in 1885, Tourette’s syndrome is estimated to affect one in 10 to 1000 people worldwide. A neurological ...